Overview
There is a growing interest in HIV infection and sexually transmitted infection (STI) disease burden and risk among transgender people globally, but the majority of work has considered only male-to-female (MTF) transgender people (Baral et al., 2013; Herbst et al., 2008) . This research synthesis focuses on HIV and STIs among female-tomale (FTM) transgender people. We begin with a review of transgender terminology, briefly consider the diagnostic history of transgenderism and its consequences for sexual health research, and comprehensively and critically review the research literature on HIV and STIs in FTMs globally. We then highlight gaps, opportunities, and future directions. FTMs' diverse sexual attractions, behaviours, and identities are underscored as key to understanding their HIV and STI risk, underscoring the need for gender-affirmative risk assessments that attend to the specific bioanatomies of physical bodies. Findings from this review can be used to inform future research, policy, programming, and interventions in FTM sexual health.
Transgender identity and sexuality
The term 'transgender' describes people who do not identify with the sex category assigned to them at birth, or whose gender identity or behaviour falls outside of gender norms (Currah & Minter, 2000) . Trans masculine describes people assigned a female sex at birth who identify on the masculine continuum -as male, men, FTM, transgender men, trans men, men of transgender experience, or affirmed men; or genderqueer (neither male nor female), bi-gender or pangender (both male and female), androgynous, butch, boi, aggressive, and other diverse gender identities and expressions not typically expected of female-assigned sex people. Trans masculine communities are heterogeneous, and not all trans masculine people are stereotypically 'masculine' in their interests or gender presentation. In order to be concise, this review uses 'FTM' as shorthand for transgender men and other trans masculine people, but it is important to note that not all members of the aforementioned groups identify with the 'FTM' label.
'Gender dysphoria' refers to discomfort with the gender that one was assigned at birth (Bockting, 2015) . Transgender people use a range of strategies to lessen feelings of gender dysphoria and affirm their gender identities. Gender affirmation can be thought of as having three primary dimensions: (1) social elements, such as adopting a name and pronouns that align with one's gender identity; (2) medical elements, such as masculinising hormones and/or surgeries; and (3) legal elements, such as changing one's legal name or gender designation. The process of making gender-affirming changes is known as 'gender transition', or simply 'transition'. A gender affirmation process may include any combination of social, medical, and/or legal changes, depending on individual desires, regional law and policy, financial means, life circumstances, and local norms.
It is now clear that transgender people have diverse sexual orientations, identities, and behaviours, and can be sexually attracted to people of any gender (Grant et al., 2011; Kuper, Nussbaum, & Mustanski, 2012) . Until recently, however, the study of sexual behaviour (and therefore sexual risk) in FTMs has been limited by a narrow schema of transgenderism within psychiatry and other disciplines. In the popular and professional conception of transgenderism that developed in North America and Western Europe beginning in the mid-twentieth century, 'true transsexuals' (who would now be called 'transgender') invariably wished to embody the conventional physiology, appearance, and behaviours of the 'opposite sex'. Those not expected to be gender-conforming in their new sex were denied medical treatment (Meyerowitz, 2004) . As a result of these restrictions, transgender communities learned to present themselves to physicians and psychologists as preparing to become traditionally masculine men or traditionally feminine women. Sexual orientation was a crucial part of this gender performance, since people taking on a male gender were expected to be exclusively attracted to females. As a result, many patients concealed non-heterosexual attractions from the professionals treating them, reinforcing the perception that nearly all 'transsexuals' were straight (Meyerowitz, 2004) . As late as 2013, the American Psychiatric Association (APA) held that 'virtually all [FTMs] will receive the same specifier -Sexually Attracted to Females -although there are exceptional cases involving [FTMs] who are Sexually Attracted to Males' (American Psychiatric Association, 2000) . The APA's stance was reflective of, and influential towards, research in transgender sexual health. As a result of the presumption that FTMs were sexually active almost exclusively with non-transgender women, many researchers have assumed that they are at low risk for HIV and STIs (Kenagy & Hsieh, 2005) . More recently, sexual health and sexuality research has documented diverse sexualities and sexual practices among FTMs. Indeed, recent data suggest that FTMs in North America are much less likely to be heterosexual (i.e. attracted primarily to women) than non-transgender men (Grant et al., 2011) . Furthermore, even straight-identified FTMs' sexual practices may put them at risk for HIV and STIs. For instance, they may partner with transgender women, and engage in similar HIV risk behaviours as non-transgender heterosexual couples. They may, like some non-transgender men, identify as straight but nonetheless engage in sex with other men. And certain sexual practices with non-transgender women also carry risks, including HPV exposure -particularly concerning among FTMs, given reduced rates of cervical cancer screening in this group (Peitzmeier, Khullar, Reisner, & Potter, 2014) . It is therefore essential that assessment of sexual behaviour in FTMs be attentive to the myriad of gender identities in FTMs themselves as well as the heterogeneity of their sexual partners, while also attending to the specificity of physical bodies engaged in sexual behaviours. There is a diverse range of bioanatomies potentially represented among FTMs and their partners during sexual encounters (e.g. surgically unaltered bodies, bodies that have been altered to various degrees depending on individual desires and access to medical technologies). Addressing this diversity is important for determining prevention and care needs, as well as HIV and STI sexual risk. This review captures the current empirical knowledge on how sexual identity and behaviour among FTMs produce unique HIV and STI biobehavioural risk patterns in this population.
Literature review of HIV and STI risk in FTMs

Review methodology
Peer-reviewed articles published before 1 August 2014 were collected from PubMed, Embase, Ovid, PsycINFO, CINAHL PLUS, Web of Science, Sociological Abstracts, and Medadvocates. The review included peer-reviewed articles and grey literature reports that presented FTM-specific data on sexual risk behaviour, HIV status, or STI infection. It included both qualitative and quantitative studies.
Articles and citations were downloaded from the databases and organised using citation management software (QUOSA, EndNote X5, and Zotero). In order to ensure that this review was as broad as possible, search terms included MeSH terms for 'transgender' cross-referenced with terms for 'health' and 'HIV'. We also included a range of terms similar to transgender, such as 'FTM', 'trans man', and 'transman'. Searches for peerreviewed papers were limited to material published in English. Additional data sources, including the International AIDS Society, the World Professional Association for Transgender Health, and the National Library of Medicine's Meeting Abstracts, were searched for 'grey literature' material.
Results of review
We identified 25 peer-reviewed papers (18 of which included quantitative data and 7 qualitative data). Two of the qualitative studies lack a direct focus on sexual health, but include content relevant to sexual risk behaviour. Eleven 'grey literature' sources were identified (7 posters and abstracts, 3 needs assessments, and 1 additional dataset). Overall, 81% of the included literature is quantitative or mixed-methods, and 19% is qualitative. Table 1 outlines the existing quantitative research. Ten studies had laboratory-confirmed HIV serostatus, documenting 0% (in six studies), 2.2%, 3%, and 4.3% (1 of 23) HIV seropositivity among FTMs.
1 Most studies found self-reported HIV prevalence between 0% and 10%, and self-reported unknown HIV serostatus from 5% to 57%. In comparison, the adult (ages 13+ years) HIV prevalence for the US, where the majority of the studies were conducted, is approximately 0.7% in males and 0.2% in females (Centers for Disease Control and Prevention, 2012) . However, HIV prevalence is estimated to be over 15% among US MSM (Beyrer et al., 2012) , and even higher (16-68%) among MTF transgender women (Baral et al., 2013; Herbst et al., 2008) .
One study had laboratory-confirmed STI screening data for FTMs, revealing a 5% prevalence of Chlamydia. Lifetime self-reported STI history across samples was between 6% and 47%. Across studies, 7-69% of FTMs engaged in fluid-exchange genital-genital sexual risk behaviours; this excludes Kenagy (2002) where 91% engaged in 'high risk' sexual behaviour because the author included unprotected oral sex with female partners. Several studies documented behaviours that may contribute to HIV risk, including sex work, unprotected anal or vaginal sex with male casual partners, low utilisation of STI screening and other sexual health preventive services, and high prevalence of psychological distress and substance use.
Insight into motivations for sexual risk behaviour was provided by seven qualitative studies. Table 2 summarises the results of the seven qualitative studies, all peer-reviewed, that addressed sexual risk behaviour among FTMs. These studies offer valuable insight into the psychosocial and sociocultural context of FTMs' sexual risk behaviours. The most detailed accounts have focused on 'TMSM', that is, FTMs who have sex with men.
2 According to this literature, many post-transition TMSM describe gay identities or sex with men as a source of validation for their male identities (Bockting, Benner, & Coleman, 2009; Hein & Kirk, 1999; Williams, Weinberg, & Rosenberger, 2013) . However, acceptance from male partners is at times uncertain or tenuous, and FTMs sometimes make riskier sexual choices, like agreeing to sex without a barrier, in order to avoid rejection (Clements, Kitano, Wilkinson, & Marx, 1999; Reisner, Perkovich, & Mimiaga, 2010; Rowniak & Chesla, 2013) . Some non-transgender men may even attempt to sexually manipulate or coerce FTMs by questioning their gender (Reisner et al., 2010; Rowniak & Chesla, 2013) .
The qualitative literature reveals that some TMSM engage in risk behaviours as they explore a new sexual identity, or integrate into a new community or sexual subculture, during or after gender transition. Some FTMs describe a phase of post-transition sexual experimentation, which may involve incidental or intentional risk-taking behaviour (Clements et al., 1999) . FTMs who join gay men's communities may be particularly sensitive to norms around HIV infection. In communities where HIV-positive status is perceived as normative, FTMs may feel that seroconversion will increase their sense of belonging, and may conceal their HIV-negative status to avoid rejection by HIV-positive partners (Rowniak & Chesla, 2013) . In contrast, in communities where HIV-positive status is stigmatised, FTMs may be motivated to avoid HIV infection (Hein & Kirk, 1999) , but HIV-positive FTMs may feel doubly marginalised.
Qualitative research has focused on TMSM because they are expected to engage in the highest-risk behaviours, such as anal-penile and vaginal-penile intercourse, more frequently than FTMs who are not sexually active with men. While this attention may be warranted, it should not be to the exclusion of non-MSM FTMs. Some of the TMSM findings can be generalised: the 'gender role trigger', for instance, may contribute to coercion by partners of any gender. The 'gender role trigger' refers to engaging in behaviours that are consistent with gender role-based expectations and that validate or affirm a current male gender identity, even when such behaviours may place individuals at risk for HIV or STIs. Other dynamics may vary by sexual identity and partner choice. Future research should explore risks specific to FTMs of other sexual identities, including those who have sex with transgender women.
Gaps and opportunities
There are notable gaps in the epidemiologic literature on HIV and STI risk in FTMs. The most glaring gap is the dearth of research assessing HIV and STIs in this population, and Williams et al. (2013) Interviews with 25 FTMs in San Francisco. Discusses gay trans men, sexual identity as 'bottom' (receptive partner), and sex with men as an affirmation of masculinity, which other studies have linked to sexual risk behaviour Reisner, White et al. (2014) ; Rowniak and Chesla (2013) . Considers role of anatomy, and hormonal and surgical interventions, in sexual behaviour Rowniak and Chesla (2013) Interviews with 17 FTMs in San Francisco. 10 participants identified as gay, and none as heterosexual. One participant became HIV positive shortly after gender transition. Another recalled undertaking risky behaviour in an effort to fit in with other gay men, many of whom had HIV. Others described trans men who have acquired HIV at male sex venues, and explained that some non-trans men 'take advantage' of FTM partners for barrier-free sex Kosenko (2011) Semi-structured interviews with transgender adults in the US, including 15 FTMs, mostly 'midtransition'. Participants described a lack of safer-sex education targeting lesbian communities, in which they had participated before transition. They also described a lack of confidence navigating sexual situations as gay males, absence of FTM-specific sexual health information, and the effect of hormone therapy on sex drive Bockting et al. (2009) Interviews and psychological assessments with 25 FTMs attracted to men (60% self-described gay, 32% bisexual, and 8% queer) in the US and Canada. FTM participants were more likely to be bisexual than non-transgender controls, were comfortable with their sexual orientation and gender identity, and were similar to controls in sexual satisfaction and self-esteem Namaste (1999) Interviews with 5 FTMs in Quebec, and a discussion group at an FTM conference in Boston. FTMs reported not considering themselves at risk for HIV, and participants cited 'low self-esteem' as contributing to sexual risk behaviour Hein and Kirk (1999) Description of an HIV risk reduction group intervention for Boston-area TMSM. The intervention focused on mutual support and strategising for the challenges the participants encountered in sexual interactions with non-trans men. Participants reported strong motivation to remain HIV negative Clements et al. (1999) Focus groups with MTF and FTM residents of San Francisco. Participants reported that 'low self-esteem' was a primary reason for sexual risk-taking, and that affirmation via sex with non-trans partners motivated sexual risk behaviour. For FTM participants, trying unprotected sex was sometimes part of a gender exploration process, body dissociation made it more difficult to practice barrier use, and sex drive changes related to hormone use increased sexual risk-taking the sexual and drug using behaviours that may render Existing studies enrol small sample sizes and rely on convenience samples, limiting generalisable prevalence estimates of HIV and STIs. Also lacking are HIV and STI incidence data. Few have used laboratory-confirmed HIV or STI results. Data on HPV infection is particularly limited. There are no studies using longitudinal cohort designs to examine sexual behaviour over time. There are few epidemiologic studies of FTM sexual risk outside the US or Canada, and data from lower-and middle-income countries are particularly sparse. Existing research is also limited by inconsistent and imprecise measurement of HIV/STI risk behaviours. Studies rarely separate vaginal and anal sex, do not examine risk by sex partner gender, and differ in timeframes of risk assessment.
Investigation of biomedical and behavioural interventions appropriate for FTM populations has been limited. We were unable to identify any data about biomedical prevention strategies such as microbicides or HIV pre-exposure prophylaxis (PrEP) in FTMs. FTMs are typically excluded from drug efficacy trials, even those that include transgender women (MTFs). When they are enrolled, FTMs have not been recruited or analysed separately. For instance, NEXT-PrEP, a safety and tolerability study of a PrEP regimen, treated FTM participants as 'female' Failure to set FTM-specific recruitment targets or document their transgender status has made it impossible to assess drug safety, acceptability, or efficacy within this group. There are also no published efficacy trials of behavioural interventions to reduce HIV and STI risk among FTMs in particular.
Addressing HIV and STI risk among FTMs also requires research into their sexual and social contexts. Little is known about FTMs' partners and sexual networks, and this information is particularly crucial in preventing HIV 'bridging' with MSM communities. Social and structural factors influencing FTMs remain under-investigated, and data are lacking about how FTM identities are conceptualised and enacted in non-Western contexts.
Recommendations for HIV and STI research in FTMs
Below we offer several recommendations to guide future research efforts based on this synthesis of current research.
Recommendation 1: routinely collect transgender status information in health surveillance
Capturing transgender identity in health surveillance systems will be essential to understanding HIV and STI prevalence for these populations. At present, most systems do not identify transgender respondents, and transgender status has been inconsistently measured and operationalised. 'Two-question' measures, which assess current gender identity separately from assigned sex at birth, appear to be the most reliable and valid approach, and have been cognitively tested with transgender and non-transgender participants in the US (Reisner, Conron, et al., 2014; Tate, Ledbetter, & Youssef, 2012) . Standardised transgender status measures should be added to venue-based and regional HIV and STI surveillance programmes, and FTM-and MTF-specific results should be routinely reported. Efforts should be made to develop survey items that can assess transgender identity in a range of languages, cultural contexts, and geographic areas.
Recommendation 2: validate and standardise sexual risk behaviour assessments Across HIV and STI research in FTMs, sexual risk behaviours are inconsistently measured and operationalised. This weakness must be addressed with the development of validated and standardised sexual risk assessments, acceptable and cognitively tested with transgender and non-transgender populations alike. Such assessments should ask about specific sexual risk behaviours with male, female, and transgender sexual partners, capturing both the participants' and sexual partners' anatomy and their gender identities. These questions will help to elucidate HIV and STI risk within groups, as well as 'bridging' between groups.
Recommendation 3: elucidate sex and gender pathways Sex and gender are recognised globally as core social determinants of health and wellbeing across a wide variety of geographic settings and contexts (World Health Organization, 2008) . Sex refers to biological differences among male, female, and intersex people, such as genetics, hormones, secondary sex characteristics, and anatomy. Gender typically refers to 'cultural meanings of patterns of behaviour, experience, and personality that are labelled masculine or feminine' (Institute of Medicine, 2011) . Gender is a multidimensional construct that is culturally dependent, and includes gender identity (internal sense of being male, female, or another gender), gender behaviours (how a person expresses their gender identity through appearance and mannerisms), and gender beliefs (cognitive beliefs about gender, gender role conformity, and gender socialisation) (Krieger, 2003) . Research in FTM health should consider each gender-related dimension's role in HIV and STI risk -alongside biological sex-linked pathways potentiating HIV infection and STIs.
Recommendation 4: account for a range of gender identities
People who transition from 'female to male' vary in their self-described gender identities. Some understand themselves as fully male, while others see themselves as some combination of male and female, or as another gender altogether. Those who identify as neither fully male nor fully female can be described as 'non-binary'. Gender identity may be context-dependent, may manifest differently across cultures and geographies, and may shift over time.
Non-binary gender identities can introduce challenges to sexuality, since partners may not understand a non-binary gender identity or be willing to affirm it. However, these identities may also result from a reflective process that leads to a more secure sense of self. Bockting et al. (2009) found that for 20% of FTMs in their sample, a binary male identity at the time of transition eventually gave way to a non-binary identity. This shift was not associated with regrets about transition; rather, non-binary identity reflected the perspectives on gender that participants developed through their transition experiences, including a rejection of conventional beliefs about what it means to be male or female. Future research should acknowledge the range of gender identities in FTMs and consider both the potential challenges and protective effects of non-binary identity for sexual health.
Recommendation 5: consider social, medical, and legal gender affirmation For FTMs, medical gender affirmation often includes cross-sex hormone therapy with testosterone, which deepens the voice, causes growth of body and facial hair, redistributes body fat to a more masculine appearance, and causes the menstrual cycle to end. Surgical interventions may include genital reconstructive surgery, mastectomy (known as chest reconstruction or 'top surgery'), and/or hysterectomy and oophorectomy. Only a minority of FTMs access genital surgeries (e.g. metoidioplasty or phalloplasty), due to a combination of costs, outcomes, complication rates, and personal preference (Grant et al., 2011) . However, testosterone therapy induces clitoral growth, which many FTMs find desirable. FTMs often describe their body parts using terms that correspond with their gender identity (e.g. penis or micro-phallus) rather than anatomical sex (i.e. clitoris) and may refer to vaginal sex as 'frontal sex' (Adams et al., 2008) . Anatomical changes that may accompany testosterone therapy or hysterectomy, such as vaginal dryness, can increase the risk of HIV and STI transmission (Sevelius, Scheim, & Giambrone, 2010) , and more research is needed to understand the biological impact of hormone therapy on per-act probability risk of HIV and STI transmission.
Gender affirmation may affect the available pool of sexual partners, choice of sexual partners, sexual behaviours, and levels of sexual comfort and safety. 'Passing' -being seen or recognised by others as the desired or identified gender -is often an outcome of medical gender affirmation, and can create both sexual opportunities and risks. Adams et al. (2008) found, for instance, that TMSM who 'passed' as male had greater access to MSM sexual networks. However, they had to contend with assumptions that they were non-transgender and had penises, forcing them to either disclose their transgender status to interested partners, facing potential rejection, or conceal their bioanatomical differences. Increased 'passing' and concurrent social acceptance might increase selfesteem, potentially reducing sexual risk behaviour (Rosario, Schrimshaw, & Hunter, 2006) , but could also heighten risk by increasing the number of available partners. Research should account for 'passing' or 'recognition' as a key outcome of gender affirmation, with multiple possible effects on sexual risk.
Recommendation 6: foreground diversity of sexual attractions, behaviours, and identities FTMs' sexual behaviours may include vaginal and/or anal sex with non-transgender women, non-transgender men, and other transgender people (Bauer, Travers, Scanlon, & Coleman, 2012; Bockting et al., 2009) . Sexual attractions and behaviours may change over the course of gender transition. For instance, 40% of 605 FTMs recruited online from 19 different countries (83% US) reported a shift in sexual orientation during gender transition, most commonly from attraction to women only to attraction to both women and men (Meier, Pardo, Labuski, & Babcock, 2013) . Post-transition FTMs' male partners are typically gay, bisexual, or queer men, rather than straight-identified men, and sex with MSM may expose FTMs to the high prevalence of HIV and STIs in these communities.
Like non-transgender people, transgender people describe their sexual identities using varying terms, which convey not only the genders of their sexual partners but also subcultural affiliations. 'Queer', for instance, is the most commonly endorsed sexual identity among FTMs in a Western context (Meier et al., 2013; Reisner, Gamarel, Dunham, Hopwood, & Hwahng, 2013) . 'Queer' was originally a derogatory slur used against LGBT people, but has been reclaimed since the early 1990s, particularly by those who reject distinct sexual identities. Communities that form around queer identity (as contrasted with lesbian, gay, or bisexual identity) have historically been more likely to embrace openly transgender people, though this is not universally true (Stryker, 2008) .
Transgender men may also participate in communities of gay-identified men, distinct from (though sometimes overlapping with) queer-identified communities. FTMs face prejudice within gay men's communities, but recent developments -including reports from the qualitative literature on TMSM (Adams et al., 2008; Bockting et al., 2009; Williams et al., 2013) , and increased production of 'gay FTM' pornography featuring encounters between transgender and non-transgender men -suggest that gay FTMs are more visible than ever before. Psychosocial dynamics, particularly stigma and efforts to avoid rejection, can put FTMs in gay communities at heightened risk for unsafe sexual encounters (Rowniak & Chesla, 2013) . Nonetheless, for some FTMs, gay identity is crucial in developing a secure sexual and social identity (Bockting et al., 2009; Hein & Kirk, 1999; Williams et al., 2013) .
Research should explore the variety of sexual subcultures that FTMs participate in, which may predict sexual practices (including safer-sex practices), degrees of stigmatisation or affirmation within sexual networks, and HIV and STI prevalence among partners. Measuring sexual identity -which may include 'straight', 'gay', 'bisexual', 'queer', or other labels -can help to capture this variability. It is not known whether North American and Western European FTMs' tendency towards non-heterosexual identities and behaviours extends to other cultural contexts; more information is needed on FTMs' sexual attractions, behaviours, and identities in different languages, contexts, and geographic regions.
Recommendation 7: integrate health and human rights perspectives
Identifying the cultural context and consequences of pathologisation is an important step towards human rights for FTMs globally. Social exclusion and repressive (or insufficiently supportive) environments contribute to stigma in health care settings, limit access to health and HIV services, and restrict materials and publications relating to sexual health. The need for protection from non-consensual interventions (such as reparative or conversion therapy, or even 'corrective' rape intended to suppress gender-variant identities) is particularly urgent. Sexual health risks in FTMs may be heightened by discrimination in other aspects of life, including employment, housing, and education, that produces social and economic insecurity. For instance, the results of this review suggest that sex work and transactional sex are not unusual among FTMs (Herbst et al., 2008; Reisner et al., 2010; Schulden et al., 2008) , representing one path by which economic marginalisation can put FTMs at heightened risk for HIV and STIs. Special attention should be paid to the sexual health needs of FTMs in lower-and middle-income countries, a topic on which additional data is sorely needed.
Recommendation 8: engage FTM communities
Involving FTM communities -research 'with' not 'on' FTMs -is essential to creating responsive, culturally competent public health research and advocacy efforts. The principles of community-based participatory research (CBPR) represent one potentially valuable framework for research and interventions with FTMs (Leung, Yen, & Minkler, 2004 ). This approach is consistent with depathologisation and human rights perspectives used to advance transgender health research and advocacy in global contexts (International Stop Trans Pathologization Campaign, 2012) . Community engagement also ensures that research centres the needs and preferences of local FTMs. Given the extreme variation and rapid evolution of FTM identities and norms, this specificity and local engagement of community is indispensable.
Conclusion: the way forward
There is a paucity of data on HIV infection and STIs in FTMs, making it difficult to assess HIV and STI risk in this population. The general lack of awareness about transgender people, and FTMs specifically, exacerbates the problem leaving a large scientific gap. There is inadequate research to assess or determine the nature or level of risk in this population, including the sexual and drug using behaviours rendering FTMs vulnerable to HIV and STIs. Research and interventions with sexual minority populations (e.g. MSM) should be expected to justify their exclusion or inclusion of FTMs to ensure scientific accountability. Studies of MSM should seriously consider including and documenting TMSM sexual risk, and should offer a rationale for any decision to exclude them. Research and interventions with MTFs should consider the needs of local FTMs, and determine whether their work may be of value to this population, particularly in light of shared challenges like sex work and limited health care access. Furthermore, FTM communities worldwide need research, policy, and programming designed for their unique sexual health needs. These projects must consider the diverse sexual identities, attractions, and behaviours in this subpopulation, and should engage local FTM communities in needs assessment, decision-making, and implementation of public health research, policy, and programming.
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